XML 56 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Tables)
12 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Activity related to warrants
BioTime has issued warrants to purchase its common shares.  Activity related to warrants in 2013, 2012, and 2011 is presented in the table below:

 
 
Number of
Warrants
  
Per share
exercise price
  
Weighted
Average
Exercise Price 
Outstanding, January 1, 2011
  
649,000
  
$
0.68 - 10.00
  
$
6.42
 
Granted in 2011
  
206,613
   
10.00
   
10.00
 
Exercised in 2011
  
(219,000
)
  
0.68 - 3.00
   
1.94
 
Outstanding, December 31, 2011
  
636,613
  
$
3.00 – 10.00
  
$
9.13
 
Expired in 2012
  
(80,000
)
  
3.00
   
3.00
 
Outstanding, December 31, 2012
  
556,613
  
$
10.00
  
$
10.00
 
Granted in 2013
  
9,195,002
   
5.00
   
5.00
 
Outstanding, December 31, 2013
  
9,751,615
  
$
5.00 – 10.00
  
$
5.29
 
Summary of stock option activity for subsidiaries
A summary of all option activity under the subsidiary option plans (see Note 10) for the years ended December 31, 2013, 2012, and 2011 is as follows:

 
 
Options
Available for
Grant
  
Number of
Options
Outstanding
  
Weighted
Average
Exercise Price 
January 1, 2011
  
7,703,060
   
4,312,640
  
$
0.74
 
Added upon adoption of option plan in 2011
  
8,000,000
   
-
   
-
 
Granted in 2011
  
(4,685,000
)
  
4,685,000
   
0.36
 
Forfeited/Exercised in 2011
  
200,000
   
(200,000
)
  
0.05
 
December 31, 2011
  
11,218,060
   
8,797,640
  
$
0.56
 
Reverse stock split and change in plan in 2012
  
(3,697,014
)
  
(2,460,717
)
  
-
 
Granted in 2012
  
(1,479,490
)
  
1,479,490
   
1.39
 
Forfeited/Exercised in 2012
  
-
   
-
   
-
 
December 31, 2012
  
6,041,556
   
7,816,413
  
$
0.93
 
Increase option pool
  
500,000
   
-
   
-
 
Granted in 2013
  
(4,434,995
)
  
4,434,995
   
2.11
 
Expired/Forfeited/Exercised in 2013
  
785,000
   
(785,000
)
  
1.95
 
December 31, 2013
  
2,891,561
   
11,466,408
  
$
1.32